Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunological comparison of three inactivated EV71 vaccines in young children
ChiCTR1900026663Phase 4Not yet recruiting
- Sponsor
- Chinese Center for Disease Control and Prevention
- Start
- Oct 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4 trial of enterovirus 71 vaccine (vero cell), inactivated (3 arms), sponsored by Chinese Center for Disease Control and Prevention. Primary endpoint: EV71 neutralizing antibody seroconversion and antibody response. Planned start Oct 2019; status: not yet recruiting.
02
Drugs
enterovirus 71 vaccine (vero cell), inactivated
Beyond the preview
Go deeper on ChiCTR1900026663.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900026663.